Skip to Main Content

Author Details

Pavel Sova
Altius Institute for Biomedical Sciences
1990
36
24
PMIDPaper TitleJournal TitlePublished Year
35227527α4-Integrin deficiency in human CD34<sup>+</sup> cells engenders precocious erythroid differentiation but inhibits enucleation.Exp Hematol2022
29789357Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.Blood2018
28077642Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.J Virol2017
24850744Deep sequencing of HIV-infected cells: insights into nascent transcription and host-directed therapy.J Virol2014
25977790A comprehensive collection of systems biology data characterizing the host response to viral infection.Sci Data2014
25534508Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates.BMC Genomics2014
25359852Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance.Science2014
25116026A proteomic glimpse into the initial global epigenetic changes during HIV infection.Proteomics2014
23386435Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection.mBio2013
23631916Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus.mBio2013
22542004Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation.Virology2012
22509135Stitching together multiple data dimensions reveals interacting metabolomic and transcriptomic networks that modulate cell regulation.PLoS Biol2012
21264259Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.PLoS One2011
21933919Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line.mBio2011
21103519Bisulfite-free analysis of 5MeC-binding proteins and locus-specific methylation density using a microparticle-based flow cytometry assay.Analyst2011
19225617Development of a multiplexed bead-based assay for detection of DNA methylation in cancer-related genes.Mol Biosyst2009
19491256Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses.Cancer Res2009
18177253Role of chromatin structure in integration of helper-dependent adenoviral vectors containing the beta-globin locus control region.Hum Gene Ther2008
17548682Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia.Cancer Epidemiol Biomarkers Prev2007
16397291Fast chromatin immunoprecipitation assay.Nucleic Acids Res2006
16874361Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.Cancer Gene Ther2006
16434596Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.Cancer Epidemiol Biomarkers Prev2006
15093180A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.Mol Ther2004
11356958Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.J Virol2001
9811892Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif.Proc Natl Acad Sci U S A1998
9388463The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions.Biochem Biophys Res Commun1997
9223465Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.J Virol1997
8738432Genetic variability and function of the long terminal repeat from syncytium-inducing and non-syncytium-inducing human immunodeficiency virus type 1.AIDS Res Hum Retroviruses1996
8898759Generation of CD4+ and CD8+ T-cell clones from PBLs of HIV-1 infected subjects using herpesvirus saimiri.Nat Med1996
8764044vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.J Virol1996
7648874The human immunodeficiency virus type 1 vif gene: the road from an accessory to an essential role in human immunodeficiency virus type 1 replication.Curr Top Microbiol Immunol1995
7884906Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo.J Virol1995
8107232Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity.J Virol1994
8371360Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.J Virol1993
1710650Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides.J Gen Virol1991
1975974Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.Acta Virol1990
  • 1 - 36 of 36

Recommended Authors

Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 0
University of California
Career Start Year 2005
Number of shared co-authors 0
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Career Start Year 2005
Number of shared co-authors 0
Leidos Biomedical Research Inc.
Career Start Year 2003
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 2
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 0
MRC - University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 1998
Number of shared co-authors 0
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 1
University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 0
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 0
University of California los angeles
Career Start Year 1992
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
University of Utah
Career Start Year 1991
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 0
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 1
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 3
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 1
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year 1978
Number of shared co-authors 0
University of California at San Francisco
Career Start Year 1978
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1978
Number of shared co-authors 9
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Columbia University
Career Start Year 1973
Number of shared co-authors 1
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 4

Collaborators

University of Washington
Co-authored papers 9
University of Washington
Co-authored papers 4
University of North Carolina
Co-authored papers 4
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 4
Co-authored papers 4
University of Washington, USA Washington National Primate Research Center
Co-authored papers 3
University of Washington
Co-authored papers 3
National Center for Toxicological Research
Co-authored papers 3
University of Texas Medical Branch
Co-authored papers 3
University of Washington, USA Washington National Primate Research Center
Co-authored papers 3
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 2
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
Fred Hutchinson Cancer Research Center
Co-authored papers 2
University of North Carolina.
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 2
University of Washington
Co-authored papers 2
Co-authored papers 2
J. Craig Venter Institute
Co-authored papers 1
University of Washington
Co-authored papers 1
University of North Carolina at Chapel Hill.
Co-authored papers 1
University of North Carolina
Co-authored papers 1
Co-authored papers 1
The University of North Carolina at Chapel Hill
Co-authored papers 1
United States Army Medical Research Institute of Infectious Diseases
Co-authored papers 1
Pacific Northwest National Laboratory
Co-authored papers 1
Pacific Northwest National Laboratory
Co-authored papers 1
St. Jude Children's Research Hospital
Co-authored papers 1
Center for Infectious Disease Research
Co-authored papers 1
The University of North Carolina at Chapel Hill
Co-authored papers 1